Centre of Excellence in Nutraceuticals inaugurated by the Hon’ble Chief Minister of Kerala

T’puram: Chief minister Pinarayi Vijayan virtually inaugurated a centre of excellence in nutraceuticals (CoEN) at Bio 360 Life Sciences Park, Thonnakkal, on Monday.

The initiative, spearheaded by Kerala State Council for Science, Technology and Environment (KSCSTE), with support from Kerala Development and Innovation Strategic Council (K-DISC) and Kerala State Industrial Development Corporation (KSIDC) and financial assistance from KIIFB, aims to position state as a leading hub for research and innovation in the rapidly expanding nutraceutical sector.

In his address, Vijayan highlighted the growing global relevance of nutraceuticals in addressing modern health challenges. “Bioactive compounds derived from food play an important role in enhancing immunity, preventing diseases and managing chronic conditions. The establishment of a centre of excellence in nutraceuticals marks a significant milestone in Kerala’s efforts to advance science-based preventive healthcare,” he said.

The centre began functioning at the campus of Institute of Advanced Virology (IAV) within Bio 360 Life Sciences Park and was allotted 5 acres for developing its dedicated infrastructure. The project will be implemented in phases, with Rs 13.99 crore sanctioned by KIIFB over a 5-year period.

Presenting the institutional roadmap, E Sreekumar, chief executive officer of CoEN, said Phase 1 will focus on research, technology development and scientific validation of nutraceutical formulations, particularly in areas related to metabolic health and wellness. Phase 2 will establish an enterprise division to facilitate manufacturing, technology transfer and commercialisation of research outcomes in collaboration with industry.

In the keynote address, C Anantharamakrishnan, director of CSIR–NIIST, hailed Kerala govt for its proactive initiatives in promoting science, research and innovation, noting that such efforts are crucial for strengthening the state’s emerging bioeconomy and nutraceutical sector.

Related Posts

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid